Medina, Chrismarie C.
HRN: 21-05-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/16/2022
12/23/2022
IVT
450 Mg
8 Hrs
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes